The portfolio of our preclinical Neuropharmacology group covers various validated transgenic and non-transgenic in vivo and in vitro models for neurodegeneration such as AD, PD, for orphan diseases including HD and ALS , for lipid storage disease and dyslipidemia, and for diseases like psychosis, anxiety, schizophrenia, or autism.read more
3 Employees rate QPS Austria's Overall Culture a 88/100, which ranks it 1st against its competitors. Overall Culture scores are aggregated from all of the questions employees at a company answer on Comparably.